CGEM — Cullinan Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Cullinan Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	210	290	467	467	399
Prepaid Expenses
Total Current Assets	212	297	474	480	415
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.13	0.077	5.3	3.53	2.35
Long Term Investments
Other Long Term Assets
Total Assets	215	437	561	484	622
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	14.3	11.7	22.5	28.1	30.6
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	15.7	12.2	26.1	30.5	31.5
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	199	425	535	454	590
Total Liabilities & Shareholders' Equity	215	437	561	484	622
Total Common Shares Outstanding
Total Preferred Shares Outstanding